| PERIOD ENDING | 1-Sep-07 | 2-Jun-07 | 3-Mar-07 | 2-Dec-06 | | Total Revenue | 5,053 | 9,830 | 10,556 | 12,945 | | Cost of Revenue | 6,026 | 9,631 | 9,663 | 11,497 | | | Gross Profit | (973) | 199 | 893 | 1,448 | | | Operating Expenses | | Research Development | 371 | 547 | 657 | 755 | | Selling General and Administrative | 755 | 1,533 | 1,417 | 1,948 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,099) | (1,881) | (1,181) | (1,255) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 38 | 476 | 19 | 7 | | Earnings Before Interest And Taxes | (2,061) | (1,405) | (1,162) | (1,248) | | Interest Expense | 193 | 350 | 409 | 360 | | Income Before Tax | (2,254) | (1,755) | (1,571) | (1,608) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,254) | (1,755) | (1,571) | (1,608) | | | Non-recurring Events | | Discontinued Operations | 1,531 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (723) | (1,755) | (1,571) | (1,608) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($723) | ($1,755) | ($1,571) | ($1,608) |
|
1.52% Nasdaq 0.00%
Income Statement
